EU/3/24/2908 - orphan designation for treatment of acute myeloid leukaemia
4-(4-Methyl-piperazin-1-yl)-N-{6-[2-(4-trifluoromethyl-benzyloxy)-ethoxy]-1H-indazol-3-yl}-benzamide hemioxalate
Orphan
Human